Table 1.

Demographics and anti-PAD2 positivity.

	HC	MS	NMO	PTLD
	(n = 87)*	(n = 91)*	(n = 32)	(n = 281)*
Age (years), mean ±SD	39.9 ± 13.5	48.8 ± 12.5	49.5 ± 11.3	48.10 ± 15.74
Male, n (%)	33 (38.4%)	25 (28.4%)	8 (25.0%)	158 (56.2%)
White, n (%)	60 (69.8%)	65 (73.9%)	19 (59.4%)	257* (92.1%)
Anti-PAD2+, n (%)	5 (5.7%)	18 (19.8%)	0 (0%)	39 (13.9%)

MS, multiple sclerosis; NMO, neuromyelitis optica; HC, healthy controls; SD, standard deviation; Anti-PAD2+, anti-PAD2 antibody positive individuals.

^*Demographic data was available for 88 people with MS and 86 healthy controls, and race data was available for 279 people with PTLD.